You are here: Home » Current Affairs » Coronavirus » News
Indian-Americans hail relaxation of travel curbs for OCI cardholders
Business Standard

First Covid-19 vaccine to reach phase-1 trial is safe, say researchers

Several teams across the world are in a race to develop a vaccine for coronavirus infection

Topics
Coronavirus | Vaccine | Lockdown

Agencies 



testing
The scientists said these cells then produce the spike protein, and travel to the lymph nodes where the immune system creates antibodies

Days after US drugmaker Moderna claimed that the phase-1 trial of its Covid-19 has shown positive results, a new research published in The Lancet journal on Friday reported that vaccine, the first to reach phase-I clinical trial, is safe, well-tolerated, and capable of generating an immune response against the novel in humans.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Sat, May 23 2020. 13:30 IST

RECOMMENDED FOR YOU